Literature DB >> 10819537

Developmental studies of Brca1 and Brca2 knock-out mice.

R Hakem1, J L de la Pompa, T W Mak.   

Abstract

In humans, the inheritance of mutations in the breast cancer susceptibility genes BRCA1 and BRCA2 increases the risk of developing breast and ovarian cancer. To study their biological function and to create animal models for these cancer susceptibility genes, several strains of mice mutated in the homologous genes Brca1 and Brca2 have been generated by gene targeting. Analyses of these "knock-out" mouse mutants have provided invaluable knowledge about the function of these genes. Brca1 and Brca2 null mutants are similar in phenotype: mutations in both genes result in embryonic lethality and the developing embryos show signs of a cellular proliferation defect associated with activation of the p53 pathway. The significance of this activation, as well as the role of these cancer susceptibility genes in DNA damage repair, is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10819537     DOI: 10.1023/a:1018792200700

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  47 in total

1.  Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice.

Authors:  P E Blackshear; S M Goldsworthy; J F Foley; K A McAllister; L M Bennett; N K Collins; D O Bunch; P Brown; R W Wiseman; B J Davis
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

2.  RAB22 and RAB163/mouse BRCA2: proteins that specifically interact with the RAD51 protein.

Authors:  R Mizuta; J M LaSalle; H L Cheng; A Shinohara; H Ogawa; N Copeland; N A Jenkins; M Lalande; F W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

3.  WT-1 is required for early kidney development.

Authors:  J A Kreidberg; H Sariola; J M Loring; M Maeda; J Pelletier; D Housman; R Jaenisch
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

4.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

Review 5.  Tumor suppressor gene mutations in mice.

Authors:  T Jacks
Journal:  Annu Rev Genet       Date:  1996       Impact factor: 16.830

6.  Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2.

Authors:  S K Sharan; M Morimatsu; U Albrecht; D S Lim; E Regel; C Dinh; A Sands; G Eichele; P Hasty; A Bradley
Journal:  Nature       Date:  1997-04-24       Impact factor: 49.962

7.  A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53.

Authors:  D S Lim; P Hasty
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

8.  Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53.

Authors:  S N Jones; A E Roe; L A Donehower; A Bradley
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

9.  Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

Authors:  T Matsuyama; T Kimura; M Kitagawa; K Pfeffer; T Kawakami; N Watanabe; T M Kündig; R Amakawa; K Kishihara; A Wakeham
Journal:  Cell       Date:  1993-10-08       Impact factor: 41.582

10.  Somatic mutations in the BRCA1 gene in sporadic ovarian tumours.

Authors:  S D Merajver; T M Pham; R F Caduff; M Chen; E L Poy; K A Cooney; B L Weber; F S Collins; C Johnston; T S Frank
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

View more
  29 in total

Review 1.  Expression of BRCA1 and BRCA2 in normal and neoplastic cells.

Authors:  L A Chodosh
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-10       Impact factor: 2.673

2.  Xrcc2 is required for genetic stability, embryonic neurogenesis and viability in mice.

Authors:  B Deans; C S Griffin; M Maconochie; J Thacker
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

3.  BRCA2 minor transcript lacking exons 4-7 supports viability in mice and may account for survival of humans with a pathogenic biallelic mutation.

Authors:  Eswary Thirthagiri; Kimberly D Klarmann; Anil K Shukla; Eileen Southon; Kajal Biswas; Betty K Martin; Susan Lynn North; Valentin Magidson; Sandra Burkett; Diana C Haines; Kathleen Noer; Roberta Matthai; Lino Tessarollo; Jadranka Loncarek; Jonathan R Keller; Shyam K Sharan
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

4.  BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure.

Authors:  Krishna K Singh; Praphulla C Shukla; Adrian Quan; Jean-François Desjardins; Fina Lovren; Yi Pan; Vinay Garg; Sumandeep Gosal; Ankit Garg; Paul E Szmitko; Michael D Schneider; Thomas G Parker; William L Stanford; Howard Leong-Poi; Hwee Teoh; Mohammed Al-Omran; Subodh Verma
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

Review 5.  Mammary cancer susceptibility: human genes and rodent models.

Authors:  Claude Szpirer; Josiane Szpirer
Journal:  Mamm Genome       Date:  2007-12-01       Impact factor: 2.957

6.  Fanconi anemia-D1 due to homozygosity for the BRCA2 gene Cypriot founder mutation: A case report.

Authors:  Maria A Loizidou; Andreas Hadjisavvas; George A Tanteles; Elena Spanou-Aristidou; Kyriacos Kyriacou; Violetta Christophidou-Anastasiadou
Journal:  Oncol Lett       Date:  2015-11-02       Impact factor: 2.967

7.  Up-regulation of the interferon-related genes in BRCA2 knockout epithelial cells.

Authors:  Hong Xu; Jian Xian; Emmanuelle Vire; Steven McKinney; Vivien Wei; Jason Wong; Rebecca Tong; Tony Kouzarides; Carlos Caldas; Samuel Aparicio
Journal:  J Pathol       Date:  2014-08-28       Impact factor: 7.996

Review 8.  High Resolution View on the Regulation of Recombinase Accumulation in Mammalian Meiosis.

Authors:  Aditya N Mhaskar; Lieke Koornneef; Alex N Zelensky; Adriaan B Houtsmuller; Willy M Baarends
Journal:  Front Cell Dev Biol       Date:  2021-05-24

9.  BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.

Authors:  Akiko Horiuchi; Cuiju Wang; Norihiko Kikuchi; Ryosuke Osada; Toshio Nikaido; Ikuo Konishi
Journal:  Biomark Insights       Date:  2007-03-02

10.  Loss of the homologous recombination gene rad51 leads to Fanconi anemia-like symptoms in zebrafish.

Authors:  Jan Gregor Botthof; Ewa Bielczyk-Maczyńska; Lauren Ferreira; Ana Cvejic
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.